SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-011509
Filing Date
2019-01-17
Accepted
2019-01-17 16:05:03
Documents
7
Period of Report
2019-01-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d655025d8k.htm 8-K 20978
2 EX-1.1 d655025dex11.htm EX-1.1 248252
3 EX-5.1 d655025dex51.htm EX-5.1 7381
4 EX-99.1 d655025dex991.htm EX-99.1 8306
5 EX-99.2 d655025dex992.htm EX-99.2 8913
6 GRAPHIC g655025g0117071423066.jpg GRAPHIC 4945
7 GRAPHIC g655025g0117071615996.jpg GRAPHIC 4945
  Complete submission text file 0001193125-19-011509.txt   308891
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 19531030
SIC: 2834 Pharmaceutical Preparations